Prenatal Diagnosis of Trisomy 21 with Fetal Cells in Maternal Blood Using Comparative Genomic Hybridization

By  

Fetal Diagnosis and Therapy, Vol. 21, Iss. 1, 2005-12 ,pp. : 125-133

Karger

Access to resources Recommend Favorite

Screening for Trisomy 21 with Maternal Age, Fetal Nuchal Translucency and Maternal Serum Biochemistry at 11–14 Weeks: A Regional Experience from Germany

By  

Fetal Diagnosis and Therapy, Vol. 21, Iss. 3, 2006-04 ,pp. : 264-268

Karger

Access to resources Recommend Favorite

A Comparison of in vitro Culture of Fetal Nucleated Erythroblasts from Fetal Chorionic Villi and Maternal Peripheral Blood for Noninvasive Prenatal Diagnosis

By  

Fetal Diagnosis and Therapy, Vol. 32, Iss. 3, 2012-06 ,pp. : 194-200

Karger

Access to resources Recommend Favorite

Maternal Serum Placental Growth Hormone and Insulinlike Growth Factor Binding Proteins 1 and 3 in Pregnancies Affected by Fetal Aneuploidy and Other Abnormalities: Implications for Prenatal Diagnosis of Trisomy 21

By  

Fetal Diagnosis and Therapy, Vol. 13, Iss. 5, 1998-11 ,pp. : 291-297

Karger

Access to resources Recommend Favorite

Israeli Society of Medical Genetics NIPT Committee Opinion 072013: Non-Invasive Prenatal Testing of Cell-Free DNA in Maternal Plasma for Detection of Fetal Aneuploidy

By  

Fetal Diagnosis and Therapy, Vol. 36, Iss. 3, 2014-08 ,pp. : 242-244

Karger

Access to resources Recommend Favorite